Intervention for Adolescent Tobacco Initiation Prevention
Launched by UNIVERSITY COLLEGE, LONDON · Apr 30, 2024
Trial Information
Current as of September 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Adolescent Tobacco Initiation Prevention (IATIP) study, is looking at ways to help young people in Dhaka, Bangladesh, avoid starting to use tobacco and to improve their overall health and well-being. The trial will take place in schools and involves three sessions, each lasting 40 minutes, over three days. During these sessions, students will learn about the dangers of tobacco through lectures, interactive activities, and helpful materials focused on prevention and health promotion.
To be part of this study, participants must be Bangladeshi school students in Years 8 and 9 at one of the schools involved in the trial. Unfortunately, students with physical or mental impairments, those who cannot understand or read Bangla, or those without parental consent will not be able to participate. This study is not currently recruiting participants, but it aims to find effective ways to support adolescents in making healthy choices regarding tobacco.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Bangladeshi school adolescent
- • Students at one of the participating schools
- • Students of Years 8 and 9
- Exclusion Criteria:
- • Students of physical and mental impairment
- • don't understand and read the 'Bangla' language
- • don't have parental consent
About University College, London
University College London (UCL) is a leading global research institution renowned for its commitment to advancing healthcare through innovative clinical trials. As a prominent sponsor of clinical research, UCL leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous investigations aimed at improving patient outcomes and addressing pressing medical challenges. The institution fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring that its trials adhere to the highest ethical standards and regulatory guidelines. UCL's dedication to translating scientific discoveries into practical applications underscores its role as a vital contributor to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dhaka, Bangladesh
Patients applied
Trial Officials
Sahadat Hossain, MSPH
Principal Investigator
University College, London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported